Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
3.550
+0.304 (9.37%)
Jan 29, 2026, 1:32 PM EST - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.61 million as of January 29, 2026. Its market cap has decreased by -20.16% in one year.
Market Cap
1.61M
Enterprise Value
-1.46M
1-Year Change
-20.16%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.61M, a decrease of -97.61%. That is a compound annual growth rate of -58.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 1.47M | 21.63% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| STRATA Skin Sciences | 7.35M |
| enVVeno Medical | 6.62M |
| Nuwellis | 6.35M |
| INVO Fertility | 4.09M |
| Catheter Precision | 3.54M |
| Tivic Health Systems | 3.23M |
| Autonomix Medical | 2.92M |
| Aethlon Medical | 2.72M |